Can Onto Innovation (ONTO) Stock Reach $385?

Onto Innovation Inc. (ONTO) is a Wilmington, Massachusetts-based supplier of semiconductor process control equipment — including inspection, metrology, lithography systems and analytical software used to monitor chip manufacturing. After a sharp pullback from its 52-week high, the shares have become one of the most debated names in the semiconductor capital equipment group. The question on many investors' minds is whether the stock can climb back toward the roughly $385 average analyst price target.

Key Takeaways

• The central target of $385 is the arithmetic mean of roughly a dozen current analyst price targets reviewed for this analysis.
• With the stock near $222, reaching $385 would require a gain of about 73% — a very large move.
• Published targets span a wide range, from about $340 to $450, reflecting genuine disagreement on valuation and the memory cycle.
• Bullish arguments center on AI-driven demand, advanced packaging, and a record backlog above $1.1 billion.
• Key risks include a sector-wide de-rating, valuation compression, and the cyclicality of memory and wafer-fab equipment spending.

Analyst Price Targets and Consensus View

The central $385 target is a calculation, not an official published consensus. Reviewing individual targets that identify the analyst, firm and date — RBC Capital at $400 (Oct. 2, 2026), Goldman Sachs at $400 (Aug. 17, 2026), Jefferies at $400 (Aug. 7, 2026), Oppenheimer at $450 (June 22, 2026), Cantor Fitzgerald at $410 (June 29, 2026), Evercore ISI at $390 (Sept. 11, 2026), Morgan Stanley at $360 (Sept. 8, 2026), Needham at $360 (Aug. 7, 2026), Stifel at $350 (Aug. 7, 2026) and B. Riley at $340 (Oct. 19, 2026) — produces a mean near $386, rounded to $385. The low-to-high range is roughly $340 to $450.

The dispersion is unusually wide, and the direction of recent revisions has turned cautious. B. Riley cut its target to $340 from $390 in mid-October, citing lower multiples across the semiconductor capital equipment group, and Morgan Stanley trimmed its target to $360 from $383. Against that, RBC Capital and Goldman Sachs both initiated coverage with $400 targets during 2026, and Oppenheimer carries the Street-high $450. The reasoning behind the higher targets rests on Onto Innovation's leverage to AI-driven advanced packaging, high-bandwidth memory (HBM) inspection, and the integration of its Semilab acquisition.

Current Market Position and Path Toward the Target

As of the Oct. 21, 2026 close, ONTO traded near $222, with a 52-week range of $118.97 to $386.46 and a market capitalization of roughly $10.9 billion. The stock has risen more than 65% over the past year yet sits well below its 2026 peak — a reminder of how volatile this group has become. Moving from $222 to $385 implies about a 73% gain, which by any standard is a very large move and would take the shares essentially back to their prior high.

A path toward that level would likely require more than valuation repair. Trailing earnings are thin relative to the share price (a trailing price-to-earnings, or P/E, ratio above 80), so the stock trades on forward expectations: consensus models project revenue to accelerate to roughly $1.44 billion this year and EPS (earnings per share) to expand sharply, which lowers the forward P/E to the low-20s. Delivery on that earnings ramp — not simply multiple expansion — is the core of the bull case.

What Could Support a Move Toward the Target

• AI and advanced packaging demand. Onto Innovation's inspection and metrology tools are used in the increasingly complex processes behind HBM and heterogeneous AI packaging, a structural growth area.
• Record backlog. A backlog above $1.1 billion provides revenue visibility, with a material portion extending into 2027.
• Constructive revisions. Jefferies, Oppenheimer and Needham have all raised targets through 2026, framing recent quarters as "beat and raise" results.
• Product cycle. Analysts at Morgan Stanley and Cantor Fitzgerald point to platforms such as the Dragonfly G5 and spectroscopic ellipsometry as drivers of market-share gains.
• Strong balance sheet. Roughly $1.88 billion in cash provides capacity to fund development and the Semilab integration.

What Could Prevent the Target From Being Reached

• Sector de-rating. Recent target cuts from B. Riley and Morgan Stanley reflect lower multiples across semiconductor capital equipment, a trend that could persist if the AI-spending trade cools.
• Memory cyclicality. Onto Innovation's results are closely tied to memory and wafer-fab equipment spending, which is historically boom-and-bust.
• Valuation. A trailing P/E above 80 leaves little room for error if earnings growth disappoints.
• Execution and timing risk. Extended qualification cycles can delay revenue from new products, and the Semilab acquisition must deliver on its synergy promises.
• Macro and rates. Higher-for-longer interest rates tend to pressure richly valued growth equipment names.

Technical Levels and Market Structure

The technical picture underscores the challenge. The shares peaked near $386 in 2026 and have since retreated toward $222, meaning the $385 target sits almost exactly at that prior high — a natural resistance level. The $200 round number is a nearby psychological support zone after the recent decline, while the $300 area, where the stock traded earlier in October, represents an intermediate hurdle on any recovery. Until the stock reclaims and holds above its earlier highs, the longer-term trend structure remains in consolidation rather than confirmed uptrend.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of about 12 months, though individual firms vary, and the wide $340-to-$450 range shows materially different assumptions. Investors should watch the next quarterly earnings report (scheduled in early November 2026), revenue and EPS guidance against the $1.44 billion revenue expectation, and any further target revisions. Semiconductor sector data, memory pricing, AI capital-expenditure commentary from major chipmakers, and Federal Reserve rate decisions will also shape whether the group can re-rate. For Onto Innovation specifically, commentary on the Semilab integration and Dragonfly G5 adoption are the most company-specific signals.

AI Daily Buy/Sell Signals

For traders seeking a more systematic read on shifting momentum, Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell or Hold signals from changing market conditions, technical behavior and AI-driven analysis. The tool is designed to help users discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening allows. Signals are meant to complement — not replace — fundamental research, but they can be a useful way to stay attuned to fast-moving names like ONTO.

Final Assessment

Can Onto Innovation reach $385? The target is arithmetically derived from current Street estimates and sits roughly 73% above the latest price — a very large move that would return the stock to its prior high. The bull case is real: AI-driven advanced packaging, a record backlog and accelerating earnings expectations give the target a coherent foundation. But the obstacles are equally substantial, including a cooling of semiconductor equipment valuations, memory-cycle risk and a demanding trailing multiple. The $340-to-$450 analyst range captures that tension. Reaching $385 would require sustained earnings delivery and a re-rating of the sector, not just a technical bounce. Investors should monitor earnings guidance, backlog trends and analyst revisions rather than treat the $385 figure as a forecast or a guarantee.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations